APO RESEARCH · REPORT
Nuclease
A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.
Product & engineering
Understand the product.
A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.
Selected research
Industry Research
Nuclease Industry Research Report 2026
Market perspective
A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.
The global well-known brands in Nuclease include New England Biolabs(14.61%), MercK(7.28%), Illumina(6.73%), Thermo Fisher Scientific(4.51%), Agilent Technologies(3.84%), Cytiva(2.99%), Roche(2.94%), Takara Bio(2.47%), C-LEcta(1.90%), Aldevron(1.72%), Lucigen(1.39%), Promega Corporation(1.26%), Qiagen(1.01%), Amicogen(0.60%), Codexis(0.51%), BBI Solution(0.31%) and Others(45.95%).
The application area of Nuclease includes Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers and Other.
Read the full market overview
In terms of types, Nuclease can be divided into DNases and RNases.
On basis of geography, Nuclease is manufactured in North America, Europe, Japan and Korea.
Report Scope
This report quantifies the global Nuclease market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nuclease Market by Company
New England Biolabs
MercK
Illumina
Thermo Fisher Scientific
Agilent Technologies
Cytiva
Roche
Takara Bio
C-LEcta
Aldevron
Lucigen
Promega Corporation
Qiagen
Amicogen
Codexis
BBI Solution
Nuclease Segment by Type
DNases
RNases
Nuclease Segment by Application
Academic & Research Institutes
Biopharmaceutical
Hospitals & Diagnostic Centers
Other
Nuclease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nuclease manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nuclease by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNases
- RNases
Applications
- Academic & Research Institutes
- Biopharmaceutical
- Hospitals & Diagnostic Centers
- Other
Companies covered
- New England Biolabs
- MercK
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Cytiva
- Roche
- Takara Bio
- C-LEcta
- Aldevron
- Lucigen
- Promega Corporation
- Qiagen
- Amicogen
- Codexis
- BBI Solution
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nuclease Market Size (2021-2032)
- 2.2.2 Global Nuclease Sales (2021-2032)
- 2.2.3 Global Nuclease Market Average Price (2021-2032)
- 2.3 Nuclease by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DNases
- 2.3.3 RNases
- 2.4 Nuclease by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Academic & Research Institutes
- 2.4.3 Biopharmaceutical
- 2.4.4 Hospitals & Diagnostic Centers
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nuclease Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nuclease Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Nuclease Revenue of Manufacturers (2021-2026)
- 3.4 Global Nuclease Average Price by Manufacturers (2021-2026)
- 3.5 Global Nuclease Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nuclease, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nuclease, Product Type & Application
- 3.8 Global Manufacturers of Nuclease, Established Date
- 3.9 Global Nuclease Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 New England Biolabs
- 4.1.1 New England Biolabs Company Information
- 4.1.2 New England Biolabs Business Overview
- 4.1.3 New England Biolabs Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 New England Biolabs Nuclease Product Portfolio
- 4.1.5 New England Biolabs Recent Developments
- 4.2 MercK
- 4.2.1 MercK Company Information
- 4.2.2 MercK Business Overview
- 4.2.3 MercK Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 MercK Nuclease Product Portfolio
- 4.2.5 MercK Recent Developments
- 4.3 Illumina
- 4.3.1 Illumina Company Information
- 4.3.2 Illumina Business Overview
- 4.3.3 Illumina Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Illumina Nuclease Product Portfolio
- 4.3.5 Illumina Recent Developments
- 4.4 Thermo Fisher Scientific
- 4.4.1 Thermo Fisher Scientific Company Information
- 4.4.2 Thermo Fisher Scientific Business Overview
- 4.4.3 Thermo Fisher Scientific Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Thermo Fisher Scientific Nuclease Product Portfolio
- 4.4.5 Thermo Fisher Scientific Recent Developments
- 4.5 Agilent Technologies
- 4.5.1 Agilent Technologies Company Information
- 4.5.2 Agilent Technologies Business Overview
- 4.5.3 Agilent Technologies Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Agilent Technologies Nuclease Product Portfolio
- 4.5.5 Agilent Technologies Recent Developments
- 4.6 Cytiva
- 4.6.1 Cytiva Company Information
- 4.6.2 Cytiva Business Overview
- 4.6.3 Cytiva Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cytiva Nuclease Product Portfolio
- 4.6.5 Cytiva Recent Developments
- 4.7 Roche
- 4.7.1 Roche Company Information
- 4.7.2 Roche Business Overview
- 4.7.3 Roche Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Roche Nuclease Product Portfolio
- 4.7.5 Roche Recent Developments
- 4.8 Takara Bio
- 4.8.1 Takara Bio Company Information
- 4.8.2 Takara Bio Business Overview
- 4.8.3 Takara Bio Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Takara Bio Nuclease Product Portfolio
- 4.8.5 Takara Bio Recent Developments
- 4.9 C-LEcta
- 4.9.1 C-LEcta Company Information
- 4.9.2 C-LEcta Business Overview
- 4.9.3 C-LEcta Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 C-LEcta Nuclease Product Portfolio
- 4.9.5 C-LEcta Recent Developments
- 4.10 Aldevron
- 4.10.1 Aldevron Company Information
- 4.10.2 Aldevron Business Overview
- 4.10.3 Aldevron Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aldevron Nuclease Product Portfolio
- 4.10.5 Aldevron Recent Developments
- 4.11 Lucigen
- 4.11.1 Lucigen Company Information
- 4.11.2 Lucigen Business Overview
- 4.11.3 Lucigen Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lucigen Nuclease Product Portfolio
- 4.11.5 Lucigen Recent Developments
- 4.12 Promega Corporation
- 4.12.1 Promega Corporation Company Information
- 4.12.2 Promega Corporation Business Overview
- 4.12.3 Promega Corporation Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Promega Corporation Nuclease Product Portfolio
- 4.12.5 Promega Corporation Recent Developments
- 4.13 Qiagen
- 4.13.1 Qiagen Company Information
- 4.13.2 Qiagen Business Overview
- 4.13.3 Qiagen Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Qiagen Nuclease Product Portfolio
- 4.13.5 Qiagen Recent Developments
- 4.14 Amicogen
- 4.14.1 Amicogen Company Information
- 4.14.2 Amicogen Business Overview
- 4.14.3 Amicogen Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Amicogen Nuclease Product Portfolio
- 4.14.5 Amicogen Recent Developments
- 4.15 Codexis
- 4.15.1 Codexis Company Information
- 4.15.2 Codexis Business Overview
- 4.15.3 Codexis Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Codexis Nuclease Product Portfolio
- 4.15.5 Codexis Recent Developments
- 4.16 BBI Solution
- 4.16.1 BBI Solution Company Information
- 4.16.2 BBI Solution Business Overview
- 4.16.3 BBI Solution Nuclease Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 BBI Solution Nuclease Product Portfolio
- 4.16.5 BBI Solution Recent Developments
5 Global Nuclease Market Scenario by Region
- 5.1 Global Nuclease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nuclease Sales by Region: 2021-2032
- 5.2.1 Global Nuclease Sales by Region: 2021-2026
- 5.2.2 Global Nuclease Sales by Region: 2027-2032
- 5.3 Global Nuclease Revenue by Region: 2021-2032
- 5.3.1 Global Nuclease Revenue by Region: 2021-2026
- 5.3.2 Global Nuclease Revenue by Region: 2027-2032
- 5.4 North America Nuclease Market Facts & Figures by Country
- 5.4.1 North America Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nuclease Sales by Country (2021-2032)
- 5.4.3 North America Nuclease Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nuclease Market Facts & Figures by Country
- 5.5.1 Europe Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nuclease Sales by Country (2021-2032)
- 5.5.3 Europe Nuclease Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nuclease Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nuclease Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nuclease Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nuclease Market Facts & Figures by Country
- 5.7.1 South America Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nuclease Sales by Country (2021-2032)
- 5.7.3 South America Nuclease Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nuclease Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nuclease Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nuclease Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nuclease Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nuclease Sales by Type (2021-2032)
- 6.1.1 Global Nuclease Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Nuclease Sales Market Share by Type (2021-2032)
- 6.2 Global Nuclease Revenue by Type (2021-2032)
- 6.2.1 Global Nuclease Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nuclease Revenue Market Share by Type (2021-2032)
- 6.3 Global Nuclease Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nuclease Sales by Application (2021-2032)
- 7.1.1 Global Nuclease Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Nuclease Sales Market Share by Application (2021-2032)
- 7.2 Global Nuclease Revenue by Application (2021-2032)
- 7.2.1 Global Nuclease Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nuclease Revenue Market Share by Application (2021-2032)
- 7.3 Global Nuclease Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nuclease Value Chain Analysis
- 8.1.1 Nuclease Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nuclease Production Mode & Process
- 8.2 Nuclease Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nuclease Distributors
- 8.2.3 Nuclease Customers
9 Global Nuclease Analyzing Market Dynamics
- 9.1 Nuclease Industry Trends
- 9.2 Nuclease Industry Drivers
- 9.3 Nuclease Industry Opportunities and Challenges
- 9.4 Nuclease Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst